title: Successful treatment of CANOMAD with IVIg and rituximab.
authors: Wolfgang N
authors: WN
authors: Löscher
authors: Alexander
authors: A
authors: Woertz
authors: Monika
authors: M
authors: Wallnöfer
authors: Julia V
authors: JV
authors: Wanschitz
authors: Gerhard
authors: G
authors: Luef
mesh_terms: D000368:Aged; D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy*; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D001259:Ataxia / Q000188:drug therapy*; D005732:Gangliosides / Q000276:immunology; D006801:Humans; D007075:Immunoglobulin M / Q000627:therapeutic use; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D009886:Ophthalmoplegia / Q000188:drug therapy*; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D005732:Gangliosides; D007075:Immunoglobulin M; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D000069283:Rituximab
references: J Peripher Nerv Syst. 2010 Sep;15(3):185-95
references: 21040140
references: Neurology. 2003 Nov 11;61(9):1307-8
references: 14610153
references: J Neurol. 2011 Sep;258(9):1717-9
references: 21437663
references: J Neuroimmunol. 2001 Jan 1;112(1-2):181-7
references: 11108947
references: J Neurol Neurosurg Psychiatry. 2009 Sep;80(9):1036-9
references: 19684235
references: Neurology. 2001 Nov 27;57(10):1909-12
references: 11723289
references: Brain. 2001 Oct;124(Pt 10):1968-77
references: 11571215
references: Neurology. 2008 Nov 18;71(21):1742-4
references: 19015493
references: Ann Neurol. 2009 Mar;65(3):286-93
references: 19334068
references: J Neurol. 2010 Apr;257(4):655-7
references: 19960199